Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer

類似資料

• Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
  著者:: Van der Speeten, Kurt, 等
  出版事項: (2009)
• Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization
  著者:: Lemoine, Lieselotte, 等
  出版事項: (2019)
• Paclitaxel is the pharmacologic near perfect chemotherapy for peritoneal metastases
  著者:: Sugarbaker, Paul H., 等
  出版事項: (2021)
• Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
  著者:: Lemoine, Lieselotte, 等
  出版事項: (2016)
• Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients
  著者:: Van der Speeten, K., 等
  出版事項: (2012)